Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ACHIEVE LIFE SCIENCES, INC.

Get SEC filing alerts via email and in your feed for ACHIEVE LIFE SCIENCES, INC.

ACHV

ACHIEVE LIFE SCIENCES, INC.

About ACHIEVE LIFE SCIENCES, INC.

Achieve Life Sciences, Inc. is a late-stage clinical specialty pharmaceutical company dedicated to combating nicotine dependence through its product candidate, cytisinicline. Targeting the 29 million U.S. smokers and 11 million e-cigarette users, Achieve aims to address a significant health crisis. With FDA Breakthrough Therapy Designation, cytisinicline is positioned to become the first new prescription treatment for smoking cessation in nearly two decades, offering a promising solution with a favorable safety profile.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ACHIEVE LIFE SCIENCES, INC.

1
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports $10.2 Million Net Loss in Q1 2026, Focuses on Cytisinicline Commercialization

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports $54.6 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports $40M Net Loss and Advances Cytisinicline Development

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports $25.5 Million Net Loss and Advances Cytisinicline NDA

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports $12.8 Million Net Loss in Q1 2025, Faces Financial Challenges

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports $39.8 Million Net Loss for 2024, Highlights Clinical Advancements

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ACHIEVE LIFE SCIENCES, INC. Achieve Life Sciences Reports Financial Results, Net Loss, and Progress on Cytisinicline Development

Via official filing (AI summary) | over 1 year ago | 0 comments